Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response
โ Scribed by Ludek Pour; Hana Svachova; Zdenek Adam; Martina Almasi; Lucie Buresova; Tomas Buchler; Lucie Kovarova; Pavel Nemec; Miroslav Penka; Jiri Vorlicek; Roman Hajek
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 105 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
showed diffuse large B-cell lymphoma. She developed complete remission after treatment with 6 cycles R-CHOP (rituximab, and reduced doses of cyclophosphamide, vincristin, adriablastin, methylprednisolone). SLE became inactive and her symptoms of vasculitis resolved. ## Conclusion: We are bringing
## Abstract Hepatocyte growth factor (HGF) has been shown to be involved in angiogenesis, epithelial cell proliferation, and osteoclast activation. HGF and its receptor are expressed on myeloma cell lines and could be involved in the pathogenesis of bone destruction in multiple myeloma (MM). The ai